• Mashup Score: 0

    From deucravacitinib to roflumilast to tralokinumab and everything in between, James Del Rosso, DO, previews his upcoming Winter Clinical Miami session on new therapies.

    Tweet Tweets with this article
    • From #deucravacitinib to #roflumilast to #tralokinumab and everything in between, Dr. James Del Rosso covers everything clinicians need to know about new therapies at Winter Clinical Miami #WCM23 @fallclinical https://t.co/YvgNJDeozk

  • Mashup Score: 2

    ICYMI, some of this week’s featured content includes an exclusive interview about eczema, and articles on a new tralokinumab data, apremilast as a combination treatment, and more.

    Tweet Tweets with this article
    • ICYMI, some of this week’s featured content includes an exclusive interview about #eczema, and articles on a new #tralokinumab data, #apremilast as a combination treatment, and more. https://t.co/BVZl7oO47o https://t.co/BY8eMYZi9j

  • Mashup Score: 3

    In this exclusive video interview with Dermatology Times®, Andrew Blauvelt, MD, MBA, discusses the newest phase 3 clinical data on investigational tralokinumab as a potential treatment option in atopic dermatitis.

    Tweet Tweets with this article
    • In this exclusive video interview with Dermatology Times®, Andrew Blauvelt, MD, MBA, discusses the newest phase 3 clinical data on investigational #tralokinumab as a potential treatment option in #atopicdermatitis. https://t.co/zffbNjEtFc https://t.co/jqWONryZMq